BXR Partners LLP

BXR Partners LLP is an investment advisory firm based in London, United Kingdom, incorporated in 2010. As the investment advisory arm of BXR Group, the company focuses on identifying investment opportunities, structuring and executing acquisitions and disposals, and providing strategic advisory services. BXR Partners exclusively serves BXR Group and its affiliates, leveraging its expertise to offer financial guidance and support to portfolio companies. The firm also has advisory entities with offices in Budapest and Singapore, enhancing its ability to operate in various markets.

Bence Katai

Founding Partner

7 past transactions

Treos Bio

Venture Round in 2017
Treos Bio is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies tailored to the genetic profiles of patients. Founded in 2013 and based in San Francisco, California, the company utilizes proprietary technology and computational data science to predict individual responses to cancer treatments. Its product offerings include PEPI, a test that analyzes genetic data from saliva or blood samples to forecast immune responses, and PolyPEPI immunotherapy vaccines targeting various cancers such as melanoma, lung cancer, and breast cancer. Additionally, Treos Bio provides the PolyPEPI CDx companion diagnostic test, which helps determine the effectiveness of treatments for specific patients, allowing for personalized vaccine design. The company also offers a melanoma screening test to identify individuals at high risk for developing the disease based on genetic information.

Hoyo Hoyo Agribusiness

Venture Round in 2016
Hoyo Hoyo Agribusiness is a oilseed producers in the country, Hoyo Hoyo restores and develops a large scale agricultural concession.

Check-Cap

Debt Financing in 2014
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Isfiya, Israel, specializing in the development of a capsule-based system for colorectal cancer screening. The company's flagship product, C-Scan, employs low-dose X-rays to screen for polyps, masses, and colorectal cancers without the need for bowel preparation or invasive procedures. The C-Scan system comprises three components: the C-Scan Cap, an ingestible capsule that captures and transmits structural data; the C-Scan Track, a biocompatible device worn on the patient's back for tracking and data recording; and C-Scan View, software for processing and visualizing the collected clinical data. This innovative approach allows for the detection of clinically significant polyps with accuracy comparable to traditional colonoscopy while eliminating the need for retrieval of the capsule post-examination. Check-Cap aims to market its products in the United States, Europe, Israel, and Japan.

Malawi Mangoes

Acquisition in 2013
Malawi Mangoes is a fruit producer based in Malawi, specializing in the production of banana and mango purées. The company develops its own agricultural operations and implements smallholder sourcing schemes to enhance local farming. By fostering sustainable relationships with farmers, Malawi Mangoes aims to unify a fragmented agricultural market while addressing the increasing global demand for tropical fruit purées. Additionally, the company has established pulp processing and distribution capabilities to support its growth in this sector.

Marex Spectron

Private Equity Round in 2011
Marex Spectron is a global commodity broker with a focus on Metals, Agricultural, and Energy products. They provide a wide range of services to a diverse client base, backed by proprietary technology and analytics. Marex Spectron stands out in the industry for their comprehensive coverage across multiple commodity categories, including Metals, Energy, and Agricultural products, setting them apart from competitors who may specialize in only one area. With platform scalability and top rankings in various sectors, Marex Spectron is a leading player in the commodity brokerage market.

Central European Petroleum

Private Equity Round in 2010
Central European Petroleum is a petroleum exploration and production company that operates within the European Union. The company is engaged in the exploration and extraction of oil and gas, as well as helium production and distribution. In addition to its primary activities, Central European Petroleum is involved in exploratory drilling and offers services related to ore-smelting and metal purification. By focusing on these sectors, the company aims to enable its clients to distribute resources on a global scale.

ETX Capital

Private Equity Round in 2009
ETX Capital is a prominent player in the CFD and spread betting market, providing a wide array of services to retail, high net worth, and institutional clients via its robust online trading platform. Specializing in multi asset and multi market derivative trading through CFDs and spread betting products, ETX Capital caters to a diverse range of investors. The company has earned recognition for its excellence in the industry, with accolades such as "Best Futures & Options Broker" and "Value for Money" in 2011.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.